KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
7.05
+0.35 (5.22%)
Nov 6, 2024, 4:00 PM EST - Market closed
KALA BIO Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
43
Market Cap
32.48M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nortech Systems | 137.53M |
Outset Medical | 114.73M |
Celularity | 33.52M |
Surrozen | 10.00M |
Lipocine | 4.80M |
Daré Bioscience | 2.84M |
Dyadic International | 1.80M |
Nexalin Technology | 150.16K |
KALA News
- 5 months ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 months ago - KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 10 months ago - KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 year ago - KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire